文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

上皮膜蛋白2(EMP2)阻断减轻小鼠氧诱导视网膜病变中的病理性新生血管

Epithelial Membrane Protein 2 (EMP2) Blockade Attenuates Pathological Neovascularization in Murine Oxygen-Induced Retinopathy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2024-01-01

该研究在小鼠氧诱导视网膜病变(OIR)模型中检验玻璃体腔注射抗EMP2抗体对病理性新生血管的作用。体外脉络膜出芽实验中30 µg/mL抗EMP2抗体使血管生长减少48%;体内4 µg/g玻璃体腔注射使新生血管减少42%,且未观察到视网膜组织学异常、视觉传导异常或体重下降。结果表明EMP2阻断可能是OIR视网膜新生血管的局部特异性治疗方式,无全身不良反应。

要点

  • 体外30 µg/mL抗EMP2抗体使脉络膜出芽血管生长较对照IgG减少48%。
  • OIR小鼠P12玻璃体腔注射4 µg/g抗EMP2抗体,P17时新生血管较对照IgG减少42%。
  • 抗EMP2抗体治疗未引起视网膜组织学异常、视觉传导异常或体重下降。

核心结论

  • 结果提示EMP2阻断可能是氧诱导视网膜病变中视网膜新生血管的局部且特异性治疗方式,且无全身不良反应。

研究设计与样本

  • 体外脉络膜出芽实验比较培养基和人IgG对照与抗EMP2抗体处理。
  • 体内对出生后7至12天暴露于高氧的野生型小鼠,在P12行玻璃体腔注射对照IgG或抗EMP2抗体,P17行铺片成像评估新生血管。
  • 评估抗EMP2抗体治疗的局部和全身效应。

主要发现

  • 30 µg/mL抗EMP2抗体处理的脉络膜出芽血管生长较对照IgG处理减少48%。
  • 4 µg/g玻璃体腔抗EMP2抗体处理的野生型OIR小鼠新生血管较IgG对照减少42%。
  • 抗EMP2抗体处理小鼠视网膜基因表达中血管发育相关通路下调,脂肪酸氧化和三羧酸循环呼吸电子传递相关基因上调。
  • 抗EMP2抗体处理的OIR小鼠未出现大体视网膜组织学异常、视觉传导异常或体重下降。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Retinopathy of prematurity (ROP) results from postnatal hyperoxia exposure in premature infants and is characterized by aberrant neovascularization of retinal blood vessels. Epithelial membrane protein-2 (EMP2) regulates hypoxia-inducible factor (HIF)-induced vascular endothelial growth factor (VEGF) production in the ARPE-19 cell line and genetic knock-out of Emp2 in a murine oxygen-induced retinopathy (OIR) model attenuates neovascularization. We hypothesize that EMP2 blockade via intravitreal injection protects against neovascularization. METHODS: Ex vivo choroid sprouting assay was performed, comparing media and human IgG controls versus anti-EMP2 antibody (Ab) treatment. In vivo, eyes from wild-type (WT) mice exposed to hyperoxia from postnatal (P) days 7 to 12 were treated with P12 intravitreal injections of control IgG or anti-EMP2 Abs. Neovascularization was assessed at P17 by flat mount imaging. Local and systemic effects of anti-EMP2 Ab treatment were assessed. RESULTS: Choroid sprouts treated with 30 µg/mL of anti-EMP2 Ab demonstrated a 48% reduction in vessel growth compared to control IgG-treated sprouts. Compared to IgG-treated controls, WT OIR mice treated with 4 µg/g of intravitreal anti-EMP2 Ab demonstrated a 42% reduction in neovascularization. They demonstrated down-regulation of retinal gene expression in pathways related to vasculature development and up-regulation in genes related to fatty acid oxidation and tricarboxylic acid cycle respiratory electron transport, compared to controls. Anti-EMP2 Ab-treated OIR mice did not exhibit gross retinal histologic abnormalities, vision transduction abnormalities, or weight loss. CONCLUSIONS: Our results suggest that EMP2 blockade could be a local and specific treatment modality for retinal neovascularization in oxygen-induced retinopathies, without systemic adverse effects.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Aguirre B, Lin MC, Araujo E, et al. Epithelial Membrane Protein 2 (EMP2) Blockade Attenuates Pathological Neovascularization in Murine Oxygen-Induced Retinopathy. Invest Ophthalmol Vis Sci. 2024. PMID: 38958972. doi:10.1167/iovs.65.8.10

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。